UA43413C2 - Method for obtaining the injection means "erikhrozid" for treating the cardiovascular diseases - Google Patents

Method for obtaining the injection means "erikhrozid" for treating the cardiovascular diseases

Info

Publication number
UA43413C2
UA43413C2 UA97125871A UA97125871A UA43413C2 UA 43413 C2 UA43413 C2 UA 43413C2 UA 97125871 A UA97125871 A UA 97125871A UA 97125871 A UA97125871 A UA 97125871A UA 43413 C2 UA43413 C2 UA 43413C2
Authority
UA
Ukraine
Prior art keywords
treating
obtaining
cardiovascular diseases
injection means
erikhrozid
Prior art date
Application number
UA97125871A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Євгенія Іванівна Затула
Евгения Ивановна Затула
Ірина Василівна Шевченко
Ирина Васильевна Шевченко
Людмила Григорівна Науменок
Людмила Григорьевна Науменок
Наталія Власівна Бігунова
Наталия Власовна Бигунова
Наталія Федорівна Маслова
Наталья Федоровна Маслова
Жанна Андріанівна Любецька
Жанна Андриановна Любецкая
Микола Єгорович Воробйов
Николай Егорович Воробьев
Original Assignee
Державний Науковий Центр Лікарських Засобів
Государственный научный центр лекарственных средств
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Державний Науковий Центр Лікарських Засобів, Государственный научный центр лекарственных средств filed Critical Державний Науковий Центр Лікарських Засобів
Priority to UA97125871A priority Critical patent/UA43413C2/en
Publication of UA43413C2 publication Critical patent/UA43413C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invention relates to the chemical and pharmaceutical industry, in particular, to the methods of obtaining the injection means for treating the cardiovascular diseases. The method of obtaining the injection means for treating the cardiovascular diseases includes the dissolution of active material in the presence of stabilizer, filtration, ampulation and sterilization of the obtained solution. Used as the active material erikhrozid is dissolved in the aqueous lemon-phosphate buffer solution from pH 6,0-7,0 at a temperature of 40-500C with the addition as the stabilizer of trilon B in concentration 0,0025-0,005 %, and sterilization conducts with 1000C for a period of 30 minutes. .
UA97125871A 1997-12-08 1997-12-08 Method for obtaining the injection means "erikhrozid" for treating the cardiovascular diseases UA43413C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA97125871A UA43413C2 (en) 1997-12-08 1997-12-08 Method for obtaining the injection means "erikhrozid" for treating the cardiovascular diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA97125871A UA43413C2 (en) 1997-12-08 1997-12-08 Method for obtaining the injection means "erikhrozid" for treating the cardiovascular diseases

Publications (1)

Publication Number Publication Date
UA43413C2 true UA43413C2 (en) 2001-12-17

Family

ID=74218804

Family Applications (1)

Application Number Title Priority Date Filing Date
UA97125871A UA43413C2 (en) 1997-12-08 1997-12-08 Method for obtaining the injection means "erikhrozid" for treating the cardiovascular diseases

Country Status (1)

Country Link
UA (1) UA43413C2 (en)

Similar Documents

Publication Publication Date Title
MY163027A (en) FORMULATION OF HUMAN ANTIBODIES FOR TREATING TNF-(α) ASSOCIATED DISORDERS
HUP0300299A2 (en) Composition comprising free amino acids
JPS56135418A (en) Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
EE03118B1 (en) Protein medicinal product and its method of preparation
IN181859B (en)
IL122665A0 (en) Method and apparatus for inactivating contaminants in blood products
DE69914084D1 (en) PHENYLACETYLGLUTAMINE, PHENYLACETYLISOGLUTAMINE, AND / OR PHENYLACETATE FOR TREATING NEOPLASTIC DISEASES
FI882605A0 (en) Method for preparing a solution with high specific volume activity from a protein having tissue plasminogen activator (t-PA) activity
ATE196255T1 (en) DETOXIFIED IMMUNOGENIC ANTIBODIES DIRECTED AGAINST A RETROVIRAL REGULATORY PROTEIN, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE IMMUNOGENE OR ANTIBODIES.
SE9300105D0 (en) STABLE PROTEIN SOLUTION
DK0839003T3 (en) Purified heat-coagulated potato protein for use in animal feed
DE60040616D1 (en) METHOD FOR TREATING MALIGNANT CELLS OF A PATIENT AND PHARMACEUTICAL COMPOSITION FOR ITS USE
DK0580829T3 (en) Extract of bacterial proteins, process for their preparation and pharmaceutical composition containing it.
NO20042011L (en) Process for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in the treatment of ulcerative colitis and Crohn's disease
ATE225171T1 (en) AMINO ACID DERIVATIVES FOR THE TREATMENT OF STROKE
DE69522702D1 (en) A STABLE AQUEOUS INFUSION SOLUTION CONTAINING A THROMBIN INHIBITOR
UA43413C2 (en) Method for obtaining the injection means "erikhrozid" for treating the cardiovascular diseases
ATE336992T1 (en) USE OF COMPOSITIONS CONTAINING ALKANEOUS ACIDS FOR THE TREATMENT OF NAIL FUNGUS DISEASES
PL306671A1 (en) Method of minimising degradation of activated protein c and pharmaceutical agent
DE60023491D1 (en) Process for the preparation of a highly purified vegetable protein with low ribonucleic acid concentration
TH19245A (en) How to prevent the breakdown of protein C
MD873G2 (en) Desinfection process
MD964G2 (en) Method for cows mastitis treatment
DE50000562D1 (en) AGENTS FOR TREATING PIGMENTATION DISORDERS
UA29106A (en) The method for treatment of vibration disease